NVIDIA

- The Senate passage of the 'GAIN AI Act' introduces new regulatory risk by potentially restricting the Administration's ability to adapt export rules and allowing private persons to overturn licensing decisions. - Chinese antitrust regulators issued a preliminary finding regarding potential violations of Mellanox acquisition terms, increasing the risk of fines or operational restrictions on networking products. - While the AI Diffusion IFR was rescinded, uncertainty remains regarding the scope and timing of replacement rules, which could impose new worldwide licensing requirements. - Infrastructure constraints, specifically energy shortages and capital limitations, pose a growing risk of delaying customer datacenter deployments and impacting future revenue recognition.

- Although USG granted licenses for certain H20 shipments to China in August 2025, zero units were shipped and zero revenue generated to date; officials now expect a 15% revenue share on future sales. - The rescinded 'AI Diffusion' IFR has been replaced by an uncertain rule, creating ongoing volatility regarding worldwide licensing requirements for data center products. - Risks of market foreclosure in China have intensified due to local competitor preferences and new government action plans that may prevent NVIDIA from designing compliant products.

- A $4.5 billion charge was incurred in Q2 FY2026 following the April 9, 2025, U.S. mandate requiring licenses for exporting H20 chips to China, leading to diminished demand and excess inventory. - The rescission of the 'AI Diffusion' IFR in May 2025 was replaced by a rule with uncertain scope, creating potential new restrictions on popular products like H200 and GB200. - Chinese regulators are investigating whether U.S. compliance discriminates against local customers, posing a risk of fines or bans on networking products. - The rise of open-source foundation models adopted on competitor platforms threatens to weaken NVIDIA's ecosystem influence and market position.

- Demand for Blackwell systems is projected to exceed supply for several quarters in FY2026, intensifying supply chain constraints and inventory risks. - US export controls continue to expand, with no licenses received to date for restricted products to China, creating a competitive disadvantage against non-US rivals. - Potential changes in Chinese government standards for data center accelerators or restrictions on components from partners like Micron could materially harm business results. - Regulatory scrutiny remains high globally, including inquiries from the French Competition Authority and compliance costs associated with the EU AI Act.